These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8021713)

  • 21. Heat shock protein expression in cerebral X-linked adrenoleukodystrophy reveals astrocyte stress prior to myelin loss.
    Görtz AL; Peferoen LAN; Gerritsen WH; van Noort JM; Bugiani M; Amor S
    Neuropathol Appl Neurobiol; 2018 Jun; 44(4):363-376. PubMed ID: 28319253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adrenoleukodystrophy with olivopontocerebellar atrophy-like lesions.
    Tateishi J; Sato Y; Suetsugu M; Takashiba T
    Clin Neuropathol; 1986; 5(1):34-9. PubMed ID: 3948452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebral inflammation in X-linked adrenoleukodystrophy.
    McGuinness MC; Smith KD
    Arch Immunol Ther Exp (Warsz); 1999; 47(5):281-7. PubMed ID: 10604233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neonatal-onset adrenoleukodystrophy in a girl.
    Haas JE; Johnson ES; Farrell DL
    Ann Neurol; 1982 Nov; 12(5):449-57. PubMed ID: 6295256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cerebral adrenomyeloneuropathy as a late type of adrenoleukodystrophy: case report].
    Siger-Zajdel M; Stradomska TJ; Rozniecki J; Zielińska M; Selmaj K
    Neurol Neurochir Pol; 2000; 34(3):579-85. PubMed ID: 10979550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic thinner intoxication: clinico-pathologic report of a human case.
    Escobar A; Aruffo C
    J Neurol Neurosurg Psychiatry; 1980 Nov; 43(11):986-94. PubMed ID: 7441282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multislice proton magnetic resonance spectroscopic imaging in X-linked adrenoleukodystrophy.
    Kruse B; Barker PB; van Zijl PC; Duyn JH; Moonen CT; Moser HW
    Ann Neurol; 1994 Oct; 36(4):595-608. PubMed ID: 7944292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neonatal adrenoleukodystrophy.
    Aubourg P; Scotto J; Rocchiccioli F; Feldmann-Pautrat D; Robain O
    J Neurol Neurosurg Psychiatry; 1986 Jan; 49(1):77-86. PubMed ID: 2420940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solvent encephalopathy.
    King MD; Day RE; Oliver JS; Lush M; Watson JM
    Br Med J (Clin Res Ed); 1981 Sep; 283(6292):663-5. PubMed ID: 6790121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Death associated with volatile substance inhalation--histologic, scanning electron microscopic and energy dispersive X-ray spectral analyses of lung tissue.
    Byard RW; Gilbert JD; Terlet J
    Forensic Sci Int; 2007 Sep; 171(2-3):118-21. PubMed ID: 17126510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain endothelial dysfunction in cerebral adrenoleukodystrophy.
    Musolino PL; Gong Y; Snyder JM; Jimenez S; Lok J; Lo EH; Moser AB; Grabowski EF; Frosch MP; Eichler FS
    Brain; 2015 Nov; 138(Pt 11):3206-20. PubMed ID: 26377633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proton MR spectroscopic and diffusion tensor brain MR imaging in X-linked adrenoleukodystrophy: initial experience.
    Eichler FS; Itoh R; Barker PB; Mori S; Garrett ES; van Zijl PC; Moser HW; Raymond GV; Melhem ER
    Radiology; 2002 Oct; 225(1):245-52. PubMed ID: 12355012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pathology of peroxisomal disorders with pathogenetic considerations.
    Powers JM
    J Neuropathol Exp Neurol; 1995 Sep; 54(5):710-9. PubMed ID: 7666061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of MRI abnormalities on WAIS-R performance in solvent abusers.
    Yamanouchi N; Okada S; Kodama K; Sakamoto T; Sekine H; Hirai S; Murakami A; Komatsu N; Sato T
    Acta Neurol Scand; 1997 Jul; 96(1):34-9. PubMed ID: 9262130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neuropathology of peroxisomal disorders; Zellweger syndrome and neonatal adrenoleukodystrophy].
    Takashima S; Houdou S; Kamei J; Hasegawa M; Mito T; Suzuki Y; Maeda K
    No To Hattatsu; 1992 Mar; 24(2):186-93. PubMed ID: 1567656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is microglial apoptosis an early pathogenic change in cerebral X-linked adrenoleukodystrophy?
    Eichler FS; Ren JQ; Cossoy M; Rietsch AM; Nagpal S; Moser AB; Frosch MP; Ransohoff RM
    Ann Neurol; 2008 Jun; 63(6):729-42. PubMed ID: 18571777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The latest evidence in the neuroscience of solvent misuse: an article written for service providers.
    Cruz SL
    Subst Use Misuse; 2011; 46 Suppl 1():62-7. PubMed ID: 21609148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Butane encephalopathy.
    Harris D; Mirza Z
    Emerg Med J; 2005 Sep; 22(9):676-7. PubMed ID: 16113204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice.
    Forss-Petter S; Werner H; Berger J; Lassmann H; Molzer B; Schwab MH; Bernheimer H; Zimmermann F; Nave KA
    J Neurosci Res; 1997 Dec; 50(5):829-43. PubMed ID: 9418970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An adult case of adrenoleukodystrophy with features of olivo-ponto-cerebellar atrophy: I. Clinical and pathological studies.
    Takada K; Onoda K; Takahashi K; Nakamura H; Taketomi T
    Jpn J Exp Med; 1987 Feb; 57(1):53-8. PubMed ID: 3476776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.